Lobbying disclosures · Lobbying report
SYK: third_quarter 2026 lobbying report
Health Information Technology issues. Labor, Health and Human Services, and Education appropriations for House and Senate. Workforce and school safety issues.
Follow SYK- Became public
- Oct 20, 2026, 2:34 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 11:07 AM EST
Why this is connected
Legal-name match: STRYKER CORPORATION is STRYKER CORP (https://www.sec.gov/Archives/edgar/data/310764/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $50,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/202c04fb-320f-4bb1-b5c4-e637f04be6e7/","filing_uuid":"202c04fb-320f-4bb1-b5c4-e637f04be6e7","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/202c04fb-320f-4bb1-b5c4-e637f04be6e7/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Beth Anne Cole","dt_posted":"2026-10-20T14:34:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 M Street, SE","registrant_address_2":"Suite 750","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":400534596,"url":"https://lda.gov/api/v1/registrants/400534596/","house_registrant_id":41161,"name":"THORN RUN PARTNERS","description":"Government Affairs Firm","address_1":"100 M Street, SE","address_2":"Suite 750","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"W. CHRISTOPHER LAMOND","contact_telephone":"+1 202-688-0225","dt_updated":"2026-07-09T09:06:40.882848-04:00"},"client":{"id":51703,"url":"https://lda.gov/api/v1/clients/51703/","client_id":51703,"name":"STRYKER CORPORATION","general_description":"Medical Technologies Corporation","client_government_entity":null,"client_self_select":false,"state":"MI","state_display":"Michigan","country":"US","country_display":"United States of America","ppb_state":"MI","ppb_state_display":"Michigan","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Health Information Technology issues. Labor, Health and Human Services, and Education appropriations for House and Senate.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64036,"prefix":null,"prefix_display":null,"first_name":"STUART","nickname":null,"middle_name":null,"last_name":"CHAPMAN","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Representative Carolyn McCarthy; Chief of Staff, Representative Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary, Representative Barbara Lee","new":false},{"lobbyist":{"id":50817,"prefix":"mr","prefix_display":"MR.","first_name":"WILLIAM","nickname":null,"middle_name":"CHRISTOPHER","last_name":"LAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148007,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"MARSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Workforce and school safety issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64036,"prefix":null,"prefix_display":null,"first_name":"STUART","nickname":null,"middle_name":null,"last_name":"CHAPMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50817,"prefix":"mr","prefix_display":"MR.","first_name":"WILLIAM","nickname":null,"middle_name":"CHRISTOPHER","last_name":"LAMOND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in SYK
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
$1K–$15K · Traded Sep 30, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 18, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
$1K–$15K · Traded Jul 22, 2026 · disclosed Aug 18, 2026
Committee overlap: Energy and CommerceTraded 8 days before earnings - Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 15, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
$1K–$15K · Traded Jun 2, 2026 · disclosed Jul 15, 2026
Committee overlap: Energy and Commerce - May 11, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.